PSVT Without the Panic: Structured Care That Works
Multiple dates available
ASCVD Playbook | Closing the Gaps, One Inning at a Time
J.A. Randy Englert, MD, FACC
Matthew Malachowski, Pharm. D., MHA
Turning the Double Play – Comprehensive Secondary Prevention
Extra Innings – Sustaining Victory Beyond the First Game
Small Ball Wins Games – Combination Therapy for Goal Attainment
Leadoff Hitter – Spotting High-Risk Players
Crossing Home Plate – Building a Winning Team Culture
Swing for the Fences – LDL-C as the Power Hitter
Hypertrophic Cardiomyopathy: Overcoming Practical Barriers to Treatment in the Era of Myosin Inhibitors
Florian Rader, MD
SCOUT-HCM: Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Joseph Rossano, MD
Hypertrophic Cardiomyopathy: Moving From Monitoring to Action in the Era of Myosin Inhibitors
When ß-Blockers Fall Short in oHCM: Time for a New Approach?
Ahmad Masri, MD, MS
Anjali Owens, MD
From Beta-Blockers to Myosin Inhibitors: Initial Decision-Making in Obstructive HCM
Redefining oHCM Care: Efficacy and Safety of Myosin Inhibitors
Michael Nassif, MD, MSc
Molecular Precision: How Myosin Inhibitors Redefine Control
Cracking the Code of Obstruction: Unmet Needs in oHCM